Company intelligence / Profile preview
Sam-On
- Ownership
- Private
- Development stage
- Other
Overview
Sam-On, commercially known as Meditec, is a family-owned, fully integrated pharmaceutical manufacturer based in Israel. Founded in 1946 by pharmacist Tzvi Zolotariov, the company specializes in the development, production, and marketing of prescription (Rx) and over-the-counter (OTC) drugs, nutritional supplements, and medical devices. Sam-On's portfolio features over 50 registered products, including well-known brands like Kalbeten for gastrointestinal relief and Calmanervin for anxiety and insomnia. The company operates GMP-compliant manufacturing facilities in Bat Yam and Caesarea, the latter under its subsidiary Medicure Technologies. Sam-On remains a trusted supplier to the Israeli healthcare system while expanding its distribution capabilities internationally.
- Therapeutic areas
- Women's HealthGastroenterologyPsychiatryEndocrinologyNeurologyCardiovascularPulmonologyHematology
- Modalities
- Small moleculeBotanical extractHerbal medicine
- Industry
- Pharma
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Sam-On.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sam-On.